Aprea Therapeutics updates corporate presentation (January 2026)

Aprea Therapeutics, Inc.

Filed updated corporate presentation as Exhibit 99.1 on January 9, 2026.
No specific financial or operational details disclosed in the filing itself.
Presentation content not provided; unable to extract material updates.

item 8.01 item 9.01

Aprea Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-002490

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.